PLUS, NCT00593151: Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C |
|
|
| Completed | 1/2 | 32 | US | Locteron (controlled-release interferon alpha 2b), PolyActive-IFNa2b, BLX-883+PolyActive, pegylated IFNa2b, PEG-Intron, PEG, 12 kDalton pegylated interferon alpha 2b | Biolex Therapeutics, Inc. | Hepatitis C | 12/08 | 03/09 | | |